Zhengye Biotechnology Holding Limited (ZYBT) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Zhengye Biotechnology Holding Limited (ZYBT) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $41.2M, listed on NASDAQ, employing roughly 278 people, carrying a beta of -2.45 to the broader market. Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. Led by Songlin Song, public since 2025-01-07.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for ZYBT as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →